Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yvona Brychtová is active.

Publication


Featured researches published by Yvona Brychtová.


European Journal of Cancer | 2012

613 Clonal Selection of TP53 Mutations in Chronic Lymphocytic Leukaemia Detected by Ultra-deep Pyrosequencing

K. Stano Kozubik; Jitka Malčíková; Martin Trbušek; Nikola Tom; Michael Doubek; Yvona Brychtová; Jana Šmardová; Jiri Mayer; Šárka Pospíšilová; Boris Tichy

patients with stage II, microsatellite stable colon cancer with clinical data and of colon mucosa samples from 50 healthy donors, obtained during routine colonoscopy using the newly developed 450,000 CpG site platform for DNA methylation studies (Illumina Infinium HumanMethylation450BeadChip). This array includes CpG and CNG sites, CpG islands/shores/shelves/isolated CpGs in the genome, non-coding RNA (microRNAs and long non-coding RNAs) and sites surrounding the transcription start sites (−200 bp to −1,500 bp, 5′-UTRs and exons 1) for coding genes, but also for the corresponding gene bodies and 3′-UTRs. This study has been developed in the context of the COLONOMICS project (www.colonomics.org) in which for those normal-tumor paired samples and controls we also have data on molecular expression, SNPs/CNVs and miRNAs. The biomarkers identified must be validated. Results and Discussion: The preliminary analysis of the methylation patterns among different groups show differences in the methylation patterns of tumor and normal mucosa. A total of 106,566 CpG sites were differentially methylated between tumor and normal tissue (at 5% significance level after Bonferroni correction). The analyses of principal component (PCA) clearly discriminate between tumor and normal tissue samples. Some tumors show a predominant tumor hypermethylation pattern while others show hypomethylation and these patterns depict tumor subgroups that are likely to have different phenotype and outcomes. Epigenetic events may contain prognostic information. Using supervised analyses we have been able to identify several potential candidates for diagnostic and prognostic biomarkers to discriminate between tumor and non-tumor tissues. Conclusion: These differences in the methylation patterns shown to be promising in predicting the diagnostic and prognosis of CRC patients based on epigenetic characteristics of the tumors and normal mucosa.


Neoplasma | 2005

Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.

Michael Doubek; Ivo Palásek; Yvona Brychtová; Buchtova I; Jiri Mayer


British Journal of Haematology | 2017

Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patients.

Barbara Kantorová; Jitka Malčíková; Kamila Brázdilová; Marek Borsky; Karla Plevová; Jana Šmardová; Lenka Radová; Nikola Tom; Martin Trbušek; Eva Divíšková; Hana Skuhrová Francová; Navrkalova; Michael Doubek; Yvona Brychtová; Jiří Mayer; Šárka Pospíšilová


Archive | 2012

Deep sequencing identifies TP53 mutations before their clonalselection by therapy in chronic lymphocytic leukemia

Martin Trbušek; Kateřina Staňo Kozubík; Jitka Malčíková; Jana Šmardová; Ludmila Šebejová; Michael Doubek; Yvona Brychtová; Miluše Svitáková; Šárka Pavlová; Marek Mráz; Karla Plevová; Vladimíra Vranová; Nikola Tom; Jiří Mayer; Šárka Pospíšilová; Boris Tichý


Neoplasma | 2011

Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.

Marta Krejčí; Yvona Brychtová; Michael Doubek; Miroslav Tomíška; Milan Navrátil; Zdeněk Ráčil; Dana Dvorakova; Ondrej Horky; Martina Lengerová; Šárka Pospíšilová; Jiri Mayer


Archive | 2017

Dopad rekurentních mutací na dobu do progrese po terapiíchzahrnujících rituximab v 1. linii u pacientů s CLL.

Michaela Hložková; Jitka Malčíková; Nikola Tom; Marek Borský; Yvona Brychtová; Michael Doubek; Anna Panovská; Eva Divíšková; Marek Mráz; Šárka Pospíšilová; Jiří Mayer; Martin Trbušek


Archive | 2017

Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency

Karla Plevová; Jitka Malčíková; Šárka Pavlová; Jana Kotašková; Lucie Poppová; Jana Šmardová; Eva Divíšková; Kristina Ďurechová; Alexandra Oltová; Yvona Brychtová; Anna Panovská; Michael Doubek; Šárka Pospíšilová


Archive | 2017

B cell receptor signaling actvity is associated with genomicdefects in chronic lymphocytic leukemia

Helena Kočková; Karla Plevová; Jitka Malčíková; Jana Kotašková; Vojtěch Bystrý; Veronika Mančíková; Martin Trbušek; Michaela Hložková; Yvona Brychtová; Michael Doubek; Šárka Pospíšilová


Archive | 2016

B cell receptor signaling activity is associated with evolutionof TP53 defects in chronic lymphocytic leukemia

Helena Kočková; Karla Plevová; Jitka Malčíková; Jana Kotašková; Yvona Brychtová; Michael Doubek; Jiří Mayer; Šárka Pospíšilová


Archive | 2016

Single cell analysis of clonality in chronic lymphocyticleukemia patients with multiple immunoglobulin generearrangement.

Kamila Brázdilová; Karla Plevová; Hana Skuhrová Francová; Helena Kočková; Magdaléna Chmelíková; Marek Borský; Kateřina Burčková; Barbara Kantorová; Boris Tichý; Hana Škabrahová; Yvona Brychtová; Jiří Mayer; Michael Doubek; Šárka Pospíšilová

Collaboration


Dive into the Yvona Brychtová's collaboration.

Top Co-Authors

Avatar

Michael Doubek

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Šárka Pospíšilová

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Jitka Malčíková

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Boris Tichý

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Karla Plevová

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Jana Šmardová

Royal Bournemouth Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Trbušek

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge